Literature DB >> 7297018

Kinetics and renal handling of cefonicid.

D Pitkin, J Dubb, P Actor, F Alexander, S Ehrlich, R Familiar, R Stote.   

Abstract

Cefonicid kinetics were determined after intravenous and intramuscular injection and the renal handling of the drug was examined, including the effect of probenecid on its excretion. Peak serum levels after 1000 and 500 mg intravenously was 221 and 91 micrograms/ml. The half-life (t1/2) was the same for both regimens (3.5 hr). Intramuscular injection of the 1000- and 500-mg doses resulted in peak serum levels of 112 and 40 micrograms/ml. When probenecid was given with the 500-mg dose, the peak serum level was 61 micrograms/ml and the time to peak level rose from 1.3 to 2.5 hr. The t1/2 after 1000 and 500 mg alone was much the same at 4.8 and 4.9 hr. The addition of probenecid to the 500-mg dose extended the t1/2 and 7.5 hr. Renal clearance, excretion, and secretion rates for cefonicid were reduced by the addition of probenecid. Cefonicid's long t1/2 and high blood levels may provide clinical efficacy with a single daily dose.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7297018     DOI: 10.1038/clpt.1981.208

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  16 in total

Review 1.  Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.

Authors:  Robert Gharavi; William Hedrich; Hongbing Wang; Hazem E Hassan
Journal:  Pharm Res       Date:  2015-05-14       Impact factor: 4.200

2.  Pharmacokinetics of cefonicid in children.

Authors:  M Furlanut; R D'Elia; E Riva; F Pasinelli
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Effect of age and renal function on cefonicid pharmacokinetics.

Authors:  J M Trang; T P Monson; B H Ackerman; F L Underwood; J T Manning; G L Kearns
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

4.  Peritoneal transport of cefonicid.

Authors:  G D Morse; T Lane; D K Nairn; J Deterding; J Curry; P Gal
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

5.  Cefonicid concentrations in serum and atrial tissue during open-heart surgery.

Authors:  R P Sterling; D J Connor; J C Norman; D A Cooley
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

6.  Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.

Authors:  S L Barriere; G J Hatheway; J G Gambertoglio; E T Lin; J E Conte
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

Review 7.  Cephalosporin-probenecid drug interactions.

Authors:  G R Brown
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

Review 8.  Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  E Saltiel; R N Brogden
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

9.  Plasma and myocardial levels of cefonicid during open-heart surgery.

Authors:  R P Sterling; D J Connor; J C Norman
Journal:  J Natl Med Assoc       Date:  1983-11       Impact factor: 1.798

10.  Renal elimination of the hypoxic cell radiosensitizer misonidazole in Wistar rats: influence of some drugs on its excretion.

Authors:  G Akel; P Canal; G Soula
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Jul-Sep       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.